Fragment-based lead discovery: challenges and opportunities

被引:17
|
作者
Sun, Chaohong [1 ]
Petros, Andrew M. [1 ]
Hajduk, Philip J. [1 ]
机构
[1] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA
关键词
Fragment-based drug design; Biologics; Off-shoring; Outsourcing; DRUG DISCOVERY; DESIGN; INHIBITORS; BIOLOGICS; BIG;
D O I
10.1007/s10822-011-9451-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.
引用
收藏
页码:607 / 610
页数:4
相关论文
共 50 条
  • [41] Novel Strategy for Three-Dimensional Fragment-Based Lead Discovery
    Yuan, Haoliang
    Lu, Tao
    Ran, Ting
    Liu, Haichun
    Lu, Shuai
    Tai, Wenting
    Leng, Ying
    Zhang, Weiwei
    Wang, Jian
    Chen, Yadong
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (04) : 959 - 974
  • [42] An Automated Microscale Thermophoresis Screening Approach for Fragment-Based Lead Discovery
    Linke, Pawel
    Amaning, Kwame
    Maschberger, Melanie
    Vallee, Francois
    Steier, Valerie
    Baaske, Philipp
    Duhr, Stefan
    Breitsprecher, Dennis
    Rak, Alexey
    JOURNAL OF BIOMOLECULAR SCREENING, 2016, 21 (04) : 414 - 421
  • [43] Fragment-based lead discovery using X-ray crystallography
    Hartshorn, MJ
    Murray, CW
    Cleasby, A
    Frederickson, M
    Tickle, IJ
    Jhoti, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 403 - 413
  • [44] Process of Fragment-Based Lead Discovery-A Perspective from NMR
    Ma, Rongsheng
    Wang, Pengchao
    Wu, Jihui
    Ruan, Ke
    MOLECULES, 2016, 21 (07):
  • [45] Genetically encoded fragment-based discovery
    Derda, Ratmir
    Ng, Simon
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 50 : 128 - 137
  • [46] Deconstructing fragment-based inhibitor discovery
    Babaoglu, Kerim
    Shoichet, Brian K.
    NATURE CHEMICAL BIOLOGY, 2006, 2 (12) : 720 - 723
  • [47] Experiences in fragment-based drug discovery
    Murray, Christopher W.
    Verdonk, Marcel L.
    Rees, David C.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 224 - 232
  • [48] The rise of fragment-based drug discovery
    Murray, Christopher W.
    Rees, David C.
    NATURE CHEMISTRY, 2009, 1 (03) : 187 - 192
  • [49] Introduction to Fragment-Based Drug Discovery
    Erlanson, Daniel A.
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 1 - 32
  • [50] The rise of fragment-based drug discovery
    Murray C.W.
    Rees D.C.
    Nature Chemistry, 2009, 1 (3) : 187 - 192